- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04315506
A Text-based Reduction Intervention for Smokeless Tobacco Cessation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Group 1: #EnufSnuff.TXT intervention For participants in the #EnufSnuff.TXT intervention, this program will occur for up to 10 weeks. The intent of this program is to reduce the number of times participants use smokeless tobacco to zero. Participants will also be provided with cessation support messages. During the first week, participants will be asked to use smokeless tobacco as per their regular habit. They will be required to text "s" every time they use smokeless tobacco . At the end of the week we will confirm how many times you dip a day on average. Based on this number participants will be texted a reduction schedule over the next several weeks to assist with cessation. During these weeks participants will be instructed not to use smokeless tobacco unless they receive a text message telling them to do so. Within 30 minutes after participants receive the text message, they will be required to respond to that message and text the study team "s" if they used smokeless tobacco. Participants will still be required to let the study team know if they used smokeless tobacco at a different time than the time we text participants. This will help the study team know if participants have followed the schedule or not. However, if the pattern continues then participants will receive a call from the study coordinator to reexamine their pattern of smokeless tobacco use and readjust your schedule.
Group 2: Enough Snuff Intervention group
Participants in the control group will be sent the Enough Snuff cessation manual. One week after it is sent, participants will then receive two text messages a week from the study for ten weeks. These messages will reference the cessation manual.
End of Intervention and 3 and 6 Month Follow-up Assessments For both study groups, participants will be asked to take a follow-up survey at end of program and 6 months after the baseline survey. At three months all participants will be sent a brief assessment about smokeless tobacco use via text. If participants have reported to the study team that they have quit using smokeless tobacco, a small percentage of participants may be asked to provide a saliva sample to check for nicotine.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27708
- Duke University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 1) 18 years of age and older
- 2) Have used smokeless tobacco for the last year, currently dip 3 or more times a day
- 3) Have an address in a rural census tract defined by a RUCC code of 4-10 and/or an IMU of 62 or lower
- 4) Interested in participating in a cessation program; and
- 5) Have access to a cell phone with unlimited texting ability.
Exclusion Criteria:
- 1) Non-English speaking;
- 2) Have smoked cigarettes or used any other tobacco product in the past 30 days (i.e., dual user) and are not willing to abstain during the intervention period
- 3) Currently participating in a smokeless tobacco cessation study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: #EnufSnuff.TXT Intervention
Scheduled gradual reduction.
Participants are asked to gradually reduce smokeless tobacco usage.
|
The SGR program will reduce smokeless tobacco until you reach zero.
The intent of this program is to reduce the number of times participants use smokeless tobacco down to zero.
Participants will also receive text-based support messages.
|
|
Active Comparator: Enough Snuff Intervention
Participants in this arm will be given the Enuff Snuff cessation manual.
|
Participants will be sent the Enough Snuff cessation manual.
One weeks after it is sent, participants will then receive text messages from the study team twice a week for ten weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Who Did Not Use Chew/Dip in the Past 7 Days (Quit)
Time Frame: 6 months post-randomization
|
Measured by self-report.
Number of participants who replied "no" the following: "In the past 7 days, have you used chew/dip?-
Yes or No".
|
6 months post-randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Withdrawal as Measured by Minnesota Nicotine Withdrawal Scale (MNWS)
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
The MNWS is a seven-item scale that measures withdrawal symptoms (i.e., irritability, anxiety, difficulty concentrating, restlessness, increased appetite or weight gain, depression, and insomnia) during the past 24 hours.
Each item was measured using a Likert scale (with 0 = not present to 4 = severe).
A nicotine withdrawal total score was derived by summing the scores for the 7-items, with a possible range from 0 to 28, and higher scores indicating greater withdrawal.
|
Baseline, 3 months, and 6 months post-randomization
|
|
Change in Craving as Measured by Smokeless Tobacco Evaluation Questionnaire (STEQ)
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
The STEQ is a 12-item scale assessing the degree to which participants experience the reinforcing effects of smokeless tobacco on a 7-point Likert scale (0= not at all to 7=Extremely).
The tool has five subscales: chewing satisfaction, psychological reward, enjoyment of sensations in cheek/gum, craving reduction, and aversion.
To assess change in craving, the one item craving reduction subscale was used for this analysis.
The question was "Did chewing/dipping immediately relieve your craving for smokeless tobacco?".
The possible range was 0= not at all to 7=Extremely.
At each timepoint, a higher score on this item indicated greater withdrawal symptom in terms of craving relief.
Thus, a decrease in the mean craving reduction score across time indicates an improvement in the withdrawal symptoms specific to craving.
|
Baseline, 3 months, and 6 months post-randomization
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Devon Noonan, PhD, Duke University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Pro00103410
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smokeless Tobacco Cessation
-
Duke UniversityNational Cancer Institute (NCI)Completed
-
Oregon Research InstituteNational Cancer Institute (NCI); Mayo ClinicCompletedSmokeless Tobacco CessationUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedSmokeless Tobacco CessationUnited States
-
HealthPartners InstituteMinnesota Partnership for Action Against TobaccoCompleted
-
Lehigh UniversityAmerican Cancer Society, Inc.RecruitingSmokeless Tobacco CessationUnited States
-
Duke UniversityCompletedSmokeless Tobacco CessationUnited States
-
Roswell Park Cancer InstituteCompletedTobacco Use | Tobacco Smoking | Cigarette Smoking | Smokeless Tobacco CessationUnited States
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm Reduction | Smokeless TobaccoSweden
-
Contract Research Organization el ABSwedish Match ABCompletedSmoking Cessation | Harm Reduction | Smokeless TobaccoSweden
-
Aga Khan UniversityDow University of Health SciencesCompletedSmokeless Tobacco CessationPakistan
Clinical Trials on #EnufSnuff.TXT Intervention
-
Duke UniversityNational Cancer Institute (NCI)Completed
-
Biolux Research Holdings, Inc.TerminatedOrthodontic Tooth MovementCanada
-
Nottingham Trent UniversityUnknownOverweight and ObesityUnited Kingdom
-
University of Southern DenmarkTrygFonden, DenmarkUnknownObesity | Overweight | Metabolic Syndrome | ChildrenDenmark
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedColorectal Carcinoma | Healthy Subject | Health Status UnknownUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8United States
-
University of FloridaCompletedSensitivityUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy
-
Vanderbilt UniversityCompletedMath Learning Disability | Reading Learning DisabilityUnited States